A medical assistant administers a MMR vaccine
A medical assistant administers a measles, mumps and rubella (MMR) vaccine at a pediatric clinic in Coral Gables, Florida, on Aug. 13, 2026. The United States has lost its measles elimination status after 26 years, following sustained transmission and a surge in cases. Getty Images

The United States has officially lost its measles elimination status after 26 years, as health authorities confirmed sustained transmission of the highly contagious virus and federal data showed more than 5,400 cases and 43 new outbreaks in 2026.

The Pan American Health Organization (PAHO), the regional office of the World Health Organization, formally confirmed the decision Tuesday, ending a public-health designation the United States had maintained since 2000.

Mexico and Bolivia also lost their elimination status after evidence showed that the same measles virus lineage had circulated continuously for at least 12 months.

The decision follows a resurgence of measles across North America, with declining vaccination rates and prolonged outbreaks reversing decades of progress in controlling the disease.

According to the Centers for Disease Control and Prevention's latest national surveillance figures, the United States recorded 5,412 confirmed cases as of November 12, compared with 2,289 throughout 2025.

The agency reported 43 new outbreaks during 2026, with approximately 96% of confirmed cases linked to outbreaks that began either this year or in 2025.

The figures represent the highest annual measles case count in the United States in more than three decades.

The CDC has confirmed six measles-related deaths this year, although state health departments have reported a higher total.

According to Reuters, states had reported 10 measles-related deaths in 2026, including seven in Pennsylvania, two in Wisconsin and one in New York.

The CDC says its national death count remains subject to revision as additional information becomes available and reviews are completed.

Measles is among the most contagious infectious diseases and spreads through the air when an infected person coughs or sneezes.

Although most patients recover, the disease can cause serious complications, including pneumonia, brain inflammation and death. Infants, young children and people with weakened immune systems are particularly vulnerable.

The United States achieved measles elimination status in 2000 after decades of vaccination efforts significantly reduced domestic transmission.

Elimination means continuous transmission of a disease has been interrupted within a country for at least 12 months. It does not mean the virus has been eradicated worldwide or that occasional imported cases cannot occur.

Under PAHO's verification framework, elimination status can be withdrawn when epidemiological and laboratory evidence establishes that the same measles virus lineage has circulated continuously for 12 months or longer.

The latest review found that endemic transmission had become reestablished in the United States, Mexico and Bolivia.

Canada previously lost its measles elimination status in November 2025 following prolonged transmission.

The resurgence has coincided with declining childhood vaccination coverage.

CDC figures show that coverage with the measles, mumps and rubella (MMR) vaccine among US kindergarten students fell from 95.2% during the 2019–2020 school year to 92.4% in 2025–2026.

The agency estimates that approximately 280,000 kindergarten students were at risk during the latest school year.

Health authorities generally recommend vaccination coverage above 95% within communities to help prevent sustained measles transmission.

However, national averages can conceal substantial gaps in protection, with some schools and communities recording considerably lower vaccination rates.

The CDC has also noted that increasing measles activity worldwide creates additional opportunities for infected travelers to introduce the virus into the United States.

Following Tuesday's confirmation, federal health officials said they remained committed to stopping outbreaks and regaining the country's elimination designation.

In an official CDC statement, Director Dr. Erica Schwartz emphasized that vaccination, rather than the designation itself, provides protection against the disease.

"The measles elimination designation is not what protects Americans. Vaccination does," Schwartz said.

The CDC said it had provided approximately $100 million in additional funding since August to state and local health departments for measles and other vaccine-preventable disease prevention and response activities.

Of that amount, $50.2 million was provided through a cooperative agreement supporting efforts to identify vaccination gaps, strengthen community partnerships and respond rapidly to outbreaks.

Another $49.8 million was allocated to strengthen epidemiological investigations, laboratory capacity, preparedness and disease detection.

The funding is intended to support prevention and response activities through much of 2027.

The CDC also said Pennsylvania and New York had requested assistance from federal epidemiological teams to support their ongoing outbreak responses.

Other states, including Texas, South Carolina, Virginia, Kansas, New Mexico and Wisconsin, previously received assistance from CDC teams.

The growing number of cases has also placed renewed attention on the broader resurgence across the Americas.

PAHO reported 58,213 confirmed measles cases and 82 deaths across the region as of November 13, underscoring the scale of transmission beyond the United States.

The organization has urged countries to improve vaccination coverage, strengthen surveillance and respond quickly to imported infections.

For the United States, regaining elimination status will require more than a reduction in reported cases.

According to Reuters, PAHO officials said the country must submit a corrective action plan outlining how it intends to interrupt sustained transmission and prevent new outbreaks.

Dr. Daniel Salas, executive manager of PAHO's Special Program for Comprehensive Immunization, said the United States was expected to submit the plan in the coming weeks.

The country must also demonstrate that sustained transmission has been interrupted for at least 12 months, supported by epidemiological and laboratory evidence.